Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals
- PMID: 22254209
- PMCID: PMC3257152
Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals
Abstract
Background: Chronic or severe acute elevations in plasma glucose are associated with decreases in the number and function of circulating angiogenic cells (CACs). However, less is known about whether fasting plasma glucose levels (FPG) within the normal or pre-diabetic range among healthy individuals are associated with decreased CAC function. Establishing this relationship is an important step in developing a line of research that may ultimately lead to preventative lifestyle interventions intended to maximize endogenous CAC function and reduce cardiometabolic disease risk.
Objectives: 1) To examine whether increases in FPG are associated with decreases in CAC migration among healthy individuals with FPG levels below the threshold for hyperglycemia, and 2) to contrast effect of FPG on CAC migration toward a pro-angiogenic stimulus (vascular endothelial growth factor; VEGF) with effect on intrinsic cell migratory capacity (i.e., random migration with no stimulus).
Methods: 28 men and women ranging from 20-57 years of age and free of cardiovascular disease participated in a pilot study, involving a fasting blood draw for FPG and isolation of peripheral blood mononuclear cells. CAC migration toward VEGF and random cell migration (control) were assessed in vitro. VEGF-induced migration that was normalized to control migration, representing the VEGF-response component of chemotaxis independent of motility, was calculated to determine whether any impairment in migration to VEGF was due to lower specific response to VEGF or to lower non-specific migratory capacity.
Results: Increased levels of FPG were associated in a dose-response fashion with a significantly lower random migration under control conditions (CTRL: r= -.408, p=.031), no differences in migration to VEGF (r= -.039, p=.842) and a borderline association with VEGF-induced migration normalized to control migration (VEGF/CTRL: r=.349, p=.069). The relationship between FPG and random migration under control conditions remained significant when controlling for gender and body mass index (p's<.05), and became borderline significant when controlling for age (p=.062).
Conclusions: Among healthy individuals, higher fasting glucose levels, despite falling below the diabetic range, are associated with decreased random CAC migration. These findings suggest a need for further studies investigating the effects of lifestyle or dietary interventions on glucose regulation and CAC function.
Keywords: Impaired fasting glucose; angiogenesis; cardiovascular; chemokinesis; chemotaxis; circulating angiogenic cells (CACs); endothelial progenitor cells (EPCs); metabolism; migration; motility; pre-diabetic.
Figures

Similar articles
-
Circulating angiogenic cell function is inhibited by cortisol in vitro and associated with psychological stress and cortisol in vivo.Psychoneuroendocrinology. 2016 May;67:216-23. doi: 10.1016/j.psyneuen.2016.02.019. Epub 2016 Feb 23. Psychoneuroendocrinology. 2016. PMID: 26925833 Free PMC article.
-
Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli.Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2212-8. doi: 10.1161/ATVBAHA.110.211581. Epub 2010 Aug 12. Arterioscler Thromb Vasc Biol. 2010. PMID: 20705916 Free PMC article.
-
Lower resting and exercise-induced circulating angiogenic progenitors and angiogenic T cells in older men.Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H392-H402. doi: 10.1152/ajpheart.00592.2017. Epub 2017 Nov 22. Am J Physiol Heart Circ Physiol. 2018. PMID: 29167123
-
The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.Dan Med J. 2017 Sep;64(9):B5400. Dan Med J. 2017. PMID: 28874244
-
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature.Diabetes Care. 2005 Nov;28(11):2626-32. doi: 10.2337/diacare.28.11.2626. Diabetes Care. 2005. PMID: 16249530 Review.
Cited by
-
Glucose and acute exercise influence factors secreted by circulating angiogenic cells in vitro.Physiol Rep. 2016 Feb;4(3):e12649. doi: 10.14814/phy2.12649. Epub 2016 Feb 4. Physiol Rep. 2016. PMID: 26847726 Free PMC article.
-
Protein engineering to develop a redox insensitive endothelial nitric oxide synthase.Redox Biol. 2014;2:156-64. doi: 10.1016/j.redox.2013.12.015. Epub 2014 Jan 14. Redox Biol. 2014. PMID: 25460726 Free PMC article.
-
Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.J Am Heart Assoc. 2016 Jan 6;5(1):e002257. doi: 10.1161/JAHA.115.002257. J Am Heart Assoc. 2016. PMID: 26738788 Free PMC article.
-
Circulating angiogenic cell function is inhibited by cortisol in vitro and associated with psychological stress and cortisol in vivo.Psychoneuroendocrinology. 2016 May;67:216-23. doi: 10.1016/j.psyneuen.2016.02.019. Epub 2016 Feb 23. Psychoneuroendocrinology. 2016. PMID: 26925833 Free PMC article.
References
-
- Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233–240. - PubMed
-
- Levitzky YS, Pencina MJ, D'Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51:264–270. - PubMed
-
- Wen CP, Cheng TY, Tsai SP, Hsu HL, Wang SL. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care. 2005;28:2756–2761. - PubMed
-
- Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care. 2004;27:1728–1734. - PubMed
-
- Dekker JM, Balkau B. Counterpoint: impaired fasting glucose: The case against the new American Diabetes Association guidelines. Diabetes Care. 2006;29:1173–1175. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources